Log In
Print
BCIQ
Print
Print this Print this
 

AIC476

  Manage Alerts
Collapse Summary General Information
Company AiCuris GmbH & Co. KG
DescriptionHuman cytomegalovirus (HCMV) maturation inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCytomegalovirus (CMV)
Indication DetailsProphylaxis and pre-emptive treatment of HVMV viremia; Treat HCMV infected HIV patients; Treat HCMV infections
Regulatory Designation

Partner

Merck & Co. Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today